ARK Genomic Revolution ETF | ARKG

High RiskEquity
ARK Genomic Revolution ETF
Issued by:ARK
Exchange : BATS
Unit Price (NAV) :
Minimum investment: 2 units
ARK Genomic Revolution ETF | ARKG

ARK Genomic Revolution ETF | ARKG


ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:


ARKG Charts
52 Week High: $|52 Week Low: $
PerformanceYTD actual1Y p.a3Y p.a5Y p.a
ARK Genomic Revolution ETF-13.34%30.25%37.85%34.20%

Asset Class

Asset type breakdown
Stock US90.92%
Stock non-US8.90%

ARKG Holdings - Top 10

NameiWeightage (%)
Teladoc Health Inc6.71%
Exact Sciences Corporation5.34%
Pacific Biosciences of California Inc4.78%
Fate Therapeutics Inc4.19%
Vertex Pharmaceuticals Incorporated4.08%
Ionis Pharmaceuticals Inc3.96%
Regeneron Pharmaceuticals Inc3.55%
Twist Bioscience Corporation3.42%
Takeda Pharmaceutical Company Limited2.98%
Accolade Inc2.98%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Basic Materials0.65%
Consumer Defensive0.34%
Financial Services0.28%

ARKG Countries

Countryi% of market value
North America92.18%
Europe Developed4.43%
Africa/Middle East0.41%

Returns Calculator

Investment ofper month
gives returns of :
at 26.15% / annum
$in 5 years
for a time period of
Returnsbased on historic SIP returns of 26.15% per annum
$+ 26.15

ARKG Summary Data

Total Net Assets $i
Average Mkt Cap Mil $i
Symbol ARKG
Exchange BATS
Asset class Equity

ARKG Key Metrics

Net Expense Ratio 0.75i
Beta 1.52i
Valuations Rates Portfolio PE 27.1223i
3 Year Standard Deviation 39.14i

ARKG Fact Sheets & Reports

About ARK

Founded in 2014, Ark is an investment manager based out of the United States of America. Ark focuses on disruptive technologies and invests specifically in innovative companies that apply them. These technologies include artificial intelligence, DNA sequencing, gene editing, robotics, electric vehicles, energy storage, fintech, 3D printing and blockchain technology. It has also invested in cryptocurrencies.

ARK Genomic Revolution ETF | ARKG